Holen Sie sich die Stockscreener-App
30.06
0.17%
0.05
Vorhandelsmarkt:
30.06
Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten
Tectonic Therapeutic (TECX) CFO receives 7,500 performance stock options at $16.80 - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: Humacyte (HUMA), Tectonic Therapeutic (TECX) - The Globe and Mail
Tectonic completes enrollment in TX45 pulmonary hypertension trial - Investing.com UK
Tectonic completes enrollment in TX45 pulmonary hypertension trial By Investing.com - Investing.com Australia
Tectonic Therapeutic Completes Enrollment in Key TX45 Trial - TipRanks
Tectonic Therapeutic (TECX) finishes TX45 Phase 2 APEX enrollment, sets early Q1 2027 data - Stock Titan
Director at Tectonic Therapeutic (TECX) awarded 10,200 options - Stock Titan
Director at Tectonic Therapeutic (TECX) granted 10,200 stock options - Stock Titan
Tectonic Therapeutic (TECX) director receives 10,200 stock options at $28.56 - Stock Titan
Director at Tectonic Therapeutic (TECX) receives 10,200 stock options expiring 2036 - Stock Titan
Tectonic Therapeutic (TECX) awards 20,400 stock options to director - Stock Titan
New Tectonic Therapeutic (TECX) director Jessica Chutter files initial Form 3 - Stock Titan
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients - GlobeNewswire
Tectonic Therapeutic (TECX) Slides 2.61% as Biotech Sector Faces PressureEquity Put Call - newsline.com
TECX: All proposals passed, with directors reelected and auditor ratified; no shareholder questions - TradingView
Tectonic Therapeutic Inc. (TECX) Advances 2.50% as Shares Test Resistance Near $30.59Continuation Pattern Picks - newsline.com
Tectonic Therapeutic (TECX) Posts 2.5% Gain as Biotech Sentiment ImprovesWyckoff Spring - newsline.com
Tectonic Therapeutic Stock Climbs as Broader Market Sinks - Bez Kabli
Tectonic Therapeutic (TECX) Surges 4.65%: Strong Momentum or Technical Resistance Ahead?Triple EMA - The Legal Advocate
Tectonic Therapeutic (TECX) Slides 1.74% as Biotech Sector Headwinds PersistWeak Sell Signals - The Legal Advocate
Tectonic Therapeutic (TECX) Slips 2.14% as Biotech Stock Consolidates Near Key SupportIV Spike - newsline.com
Raymond James upgrades Tectonic Therapeutic (TECX) - MSN
TECX Upgraded by Raymond James -- Price Target Raised to $81.00 - GuruFocus
Tectonic Therapeutic (TECX) Rallies 3.76% as Biotech Momentum Builds – Key Levels to WatchTrend Following Picks - The Legal Advocate
Tectonic Therapeutic Shares Rise After Raymond James Upgrade - Moomoo
TECX Q1 2026 Earnings: Loss Widens but Pipeline Optimism Drives Stock HigherAnalyst Drop Coverage - The Legal Advocate
Raymond James upgrades Tectonic Therapeutics stock rating on pipeline potential - Investing.com Nigeria
Raymond James Upgrades Tectonic Therapeutic to Strong Buy From Outperform, Adjusts PT to $81 From $76 - marketscreener.com
Tectonic Therapeutic (TECX) Gains 2.1% as Stock Approaches Key Resistance at $30.58SuperTrend Flip - Newser
TECX Q1 2026 Earnings: Wider-than-Expected Loss Amid Pipeline Focus; Stock Edges HigherProfitability Analysis - The Legal Advocate
TECX Q1 2026 Earnings: EPS Miss as Pre-Commercial Biotech Advances PipelineElite Trading Signals - Newser
Tectonic Therapeutic (TECX) Edges Lower as Support Levels Come into FocusSocial Trading Insights - Newser
Tectonic Therapeutic (TECX) Slips Slightly as Stock Holds Above Key SupportLeveraged ETF Flow - Newser
Tectonic Therapeutic (TECX) Q1 2026 Results Fall Short — EPS $-1.34, Revenue $N/AGuidance vs Actual - Newser
Tectonic Therapeutics: Currently In A Catalyst Vacuum (NASDAQ:TECX) - Seeking Alpha
LifeSci Capital Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $88 - Moomoo
Oppenheimer Sticks to Its Buy Rating for Tectonic Therapeutic (TECX) - The Globe and Mail
Number of shareholders of Tectonic Therapeutic, Inc. – NASDAQ:TECX - TradingView
Tectonic Therapeutic Gains 11%, Insider Trades Reap Benefit - simplywall.st
Tectonic Therapeutic (TECX) Gets a Buy from Wells Fargo - The Globe and Mail
Truist Financial Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Announces Target Price $60 - 富途牛牛
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $101 - Moomoo
MSN Money - MSN
Tectonic Therapeutic, Inc. (TECX) Eps Diluted (TTM) - Zacks Investment Research
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tectonic Therapeutic (TECX), Cullinan Management (CGEM) and Siemens Healthineers AG (OtherSEMHF) - The Globe and Mail
Mizuho Securities Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $85 - Moomoo
Piper Sandler Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $76 - Moomoo
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unveiling a Remarkable 189.87% Potential Upside - DirectorsTalk Interviews
Tectonic Therapeutic (NASDAQ:TECX) Issues Quarterly Earnings Results, Misses Expectations By $0.18 EPS - MarketBeat
TECTONIC THERAPEUTIC INC (NASDAQ:TECX) Q1 Loss Wider Than Expected, Pipeline Progress Provides Key Catalyst - ChartMill
Tectonic Therapeutic (NASDAQ: TECX) ramps R&D spend as cash tops $236M - Stock Titan
Tectonic Therapeutic (TECX) widens Q1 loss but secures cash runway into Q4 2028 - Stock Titan
Tectonic Therapeutic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Tectonic lines up two trial readouts as cash runway reaches 2028 - Stock Titan
2.60%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):